EDGAR Filing Documents for 0000929638-23-000556

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0000929638-23-000556

Filing Date

2023-02-14

Accepted

2023-02-14 15:05:14

Documents

Group Members

BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND III, LPCORMORANT PRIVATE HEALTHCARE GP III, LLC

Document Format Files

Seq	Description	Document	Type	Size
1		schedule13ga.htm	SC 13G/A	103512
	Complete submission text file	0000929638-23-000556.txt		105380

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116

Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388

Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

IRS No.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037

Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775

Longboard Pharmaceuticals, Inc. (Subject) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92379 | Film No.: 23627692
SIC: 2834 Pharmaceutical Preparations